U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Chhabra RS, Mahler J, Bristol DW, et al. NTP Genetically Modified Model Report on the Toxicology Studies of Pentaerythritol Triacrylate (Technical Grade) (CASRN 3524-68-3) in F344/N Rats, B6C3F1 Mice, and Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal Studies): NTP GMM 04 [Internet]. Research Triangle Park (NC): National Toxicology Program; 2005 Oct.

Cover of NTP Genetically Modified Model Report on the Toxicology Studies of Pentaerythritol Triacrylate (Technical Grade) (CASRN 3524-68-3) in F344/N Rats, B6C3F1 Mice, and Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal Studies)

NTP Genetically Modified Model Report on the Toxicology Studies of Pentaerythritol Triacrylate (Technical Grade) (CASRN 3524-68-3) in F344/N Rats, B6C3F1 Mice, and Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal Studies): NTP GMM 04 [Internet].

Show details

REFERENCES

  1. Albert, R.E., French, J.E., Maronpot, R., Spalding, J., and Tennant, R. (1996). Mechanism of skin tumorigenesis by contact sensitizers: The effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the TG.AC (v-Ha-ras) mouse. Environ. Health Perspect. 104, 1062–1068. [PMC free article: PMC1469494] [PubMed: 8930547]
  2. The Aldrich Library of FT-IR Spectra (1985). 1st ed. (C.J. Pouchert, Ed.), Vol. 1. Aldrich Chemical Company, Inc., Milwaukee, WI.
  3. 2000-2001 Aldrich Handbook of Fine Chemicals and Laboratory Equipment (2000), p. 1272. The Sigma-Aldrich Chemical Company. Milwaukee, WI.
  4. American Chemical Society (ACS) (1990). Chemcyclopedia ’91, p. 234. American Chemical Society, Washington, DC.
  5. American Industrial Hygiene Association (AIHA) (1981). Workplace environmental exposure level guide: Pentaerythritol triacrylate. Am. Ind. Hyg. Assoc. J. 42, B45–B46. [PubMed: 7315732]
  6. Andrews, L.S., and Clary, J.J. (1986). Review of the toxicity of multifunctional acrylates. J. Toxicol. Environ. Health 19, 149–164. [PubMed: 3531535]
  7. Argyris, T.S. (1981). The regulation of epidermal hyperplastic growth. Crit. Rev. Toxicol. 9, 151–200. [PubMed: 7026175]
  8. Ashby, J., and Tennant, R.W. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257, 229–306. [PubMed: 1707500]
  9. Ashby, J., and Tennant, R.W. (1994). Prediction of rodent carcinogenicity for 44 chemicals: Results. Mutagenesis 9, 7–15. [PubMed: 8208133]
  10. Bailer, A.J., and Portier, C.J. (1988). Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44, 417–431. [PubMed: 3390507]
  11. Barratt, M., Basketter, D., Chamberlain, M., Admans, G., and Langowski, J. (1994). An expert system rulebase for identifying contact allergens. Toxicol. In Vitro 8, 1053–1060. [PubMed: 20693071]
  12. Bauluz, C., Larcher, F., Ballestin, C., Grande, T., and Jorcano, J. (1994). Augmented expression of cytokines in mouse epidermal tumor cells and its possible involvement in the induction of hematopoietic alterations. Mol. Carcinog. 11, 155–163. [PubMed: 7945804]
  13. Bieler, G.S., and Williams, R.L. (1993). Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 49, 793–801. [PubMed: 8241374]
  14. Björkner, B. (1984). The sensitizing capacity of multifunctional acrylates in the guinea pig. Contact Dermatitis 11, 236–246. [PubMed: 6499426]
  15. Björkner, B., Dahlquist, I., and Fregert, S. (1980). Allergic contact dermatitis from acrylates in ultraviolet curing inks. Contact Dermatitis 6, 405–409. [PubMed: 6449348]
  16. Boorman, G.A., Montgomery, C.A., Jr., Eustis, S.L., Wolfe, M.J., McConnell, E.E., and Hardisty, J.F. (1985). Quality assurance in pathology for rodent carcinogenicity studies. In Handbook of Carcinogen Testing (H.A. Milman and E.K. Weisburger, Eds.), pp. 345–357. Noyes Publications, Park Ridge, NJ.
  17. Bull, J.E., Parker, D., and Turk, J.L. (1985). Predictive value of assessment of lymph node weight and T-lymphocyte proliferation in contact sensitivity in acrylates. J. Invest. Dermatol. 85, 403–406. [PubMed: 3877123]
  18. Cannon, R.E., Spalding, J.W., Trempus, C.S., Szczesniak, C.J., Virgil, K.M., Humble, M.C., and Tennant, R.W. (1997). Kinetics of wound-induced v-Ha-ras transgene expression and papilloma in transgenic Tg.AC mice. Mol. Carcinog. 20, 108–114. [PubMed: 9328441]
  19. Carpenter, C.P., Weil, C.S., and Smyth, H.F., Jr. (1974). Range finding toxicity data: List VIII. Toxicol. Appl. Pharmacol. 28, 313–319. [PubMed: 4854023]
  20. Celanese Chemical Company (1979). A Two/Four Week Dermal Toxicity Study in Rabbits (Project No. 5304-78). Submitted by Biodynamics, Inc., East Millstone, NJ, to Celanese Chemical Company, New York.
  21. Celanese Chemical Company (1981). A 28-Day Dermal Toxicity Study in Rabbits Using Test Materials C-178, C-179, C-180, C-181, C-182, C-191, and C-192 with cover letter dated 081585 (Project No. 6510-80). Submitted by Biodynamics, Inc., East Millstone, NJ, to Celanese Chemical Company, New York.
  22. Celanese Chemical Company (1982a). Celanese Multifunctional Monomers: A Guide to Application, Safety and Handling, pp. 1–35. Celanese Chemical Company, New York.
  23. Celanese Chemical Company (1982b). An Acute Intraperitoneal Toxicity Study in Rats (Project No. 6817-81). Submitted by Biodynamics, Inc., East Millstone, NJ, to Celanese Chemical Company, New York.
  24. Celanese Chemical Company (1982c). Evaluation of a Substantial Risk Submission on Pentaerythritol Triacrylate, with Enclosures. Celanese Chemical Company, New York.
  25. Celanese Corporation, Inc. (1986). Chronic Mouse Dermal Toxicity Study Using Nine Chemicals With Cover Letter Dated 081985. Submitted by Kettering Laboratory, University of Cincinnati Medical Center, Cincinnati, to Celanese Corporation, New York.
  26. Clemmensen, S. (1984). Cross-reaction patterns in guinea pigs sensitized to acrylic monomers. Drug Chem. Toxicol. 7, 527–540. [PubMed: 6534730]
  27. Code of Federal Regulations (CFR) 21, Part 58. [PubMed: 11660820]
  28. Cofield, B.G., Storrs, F.J., and Strawn, C.B. (1985). Contact allergy to aziridine paint hardener. Arch. Dermatol. 121, 373–376. [PubMed: 3156563]
  29. Cox, D.R. (1972). Regression models and life-tables. J. R. Stat. Soc. B34, 187–220.
  30. Crawford, B.D. (1985). Perspectives on the somatic mutation model of carcinogenesis. In Advances in Modern Environmental Toxicology. Mechanisms and Toxicity of Chemical Carcinogens and Mutagens (M.A. Mehlman, W.G. Flamm, and R.J. Lorentzen, Eds.), pp. 13–59. Princeton Scientific Publishing Co., Inc., Princeton, NJ.
  31. Dahlquist, I., Fregert, S., and Trulson, L. (1983). Contact allergy to trimethylolpropane triacrylate (TMPTA) in an aziridine plastic hardener. Contact Dermatitis 9, 122–124. [PubMed: 6221863]
  32. Dearfield, K.L., Millis, C.S., Harrington-Brock, K., Doerr, C.L., and Moore, M.M. (1989). Analysis of the genotoxicity of nine acrylate/methacrylate compounds in L5178Y mouse lymphoma cells. Mutagenesis 4, 381–393. [PubMed: 2687634]
  33. DePass, L.R. (1982). Carcinogenicity testing of photocurable coatings. Radiat. Curing 9, 18–24.
  34. DePass, L.R., Maronpot, R.R., and Weil, C.S. (1985). Dermal oncogenicity bioassays of monofunctional and multifunctional acrylates and acrylate-based oligomers. J. Toxicol. Environ. Health 16, 55–60. [PubMed: 4068056]
  35. DiGiovanni, J. (1991). Modification of multistage skin carcinogenesis in mice. Prog. Exp. Tumor Res. 33, 192–229. [PubMed: 1902960]
  36. Dixon, W.J., and Massey, F.J., Jr. (1951). Introduction to Statistical Analysis, 1st ed., pp. 145–147. McGraw-Hill Book Company, Inc., New York.
  37. Dunn, O.J. (1964). Multiple comparisons using rank sums. Technometrics 6, 241–252.
  38. Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096–1121.
  39. Dunson, D.B., Haseman, J.K., van Birgelen, A.P.J.M., Stasiewicz, S., and Tennant, R.W. (2000). Statistical analysis of skin tumor data from Tg.AC mouse bioassays. Toxicol. Sci. 55, 293–302. [PubMed: 10828260]
  40. Eastin, W.C., Haseman, J.K., Mahler, J.F., and Bucher, J.R. (1998). The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol. 26, 461–473. [PubMed: 9715504]
  41. Eastin, W.C., Mennear, J.H., Tennant, R.W., Stoll, R.E., Branstetter, D.G., Bucher, J.R., McCullough, B., Binder, R.L., Spalding, J.W., and Mahler, J.F. (2001). Tg.AC genetically altered mouse: Assay working group overview of available data. Toxicol. Pathol. 29, 60–80. [PubMed: 11695563]
  42. Emmett, E.A. (1977). Contact dermatitis from poly-functional acrylic monomers. Contact Dermatitis 3, 245–248. [PubMed: 145343]
  43. Emmett, E.A., and Kominsky, J.R. (1975). Health Hazard Evaluation (Report No. 75-106-247), pp.1-17. Submitted by Inmont Corporation, Paddock Road Facility, Cincinnati, OH, to the National Technical Information Service, U.S. Department of Commerce. Performed by the National Institute for Occupational Safety and Health.
  44. Emmett, E.A., and Kominsky, J.R. (1977). Allergic contact dermatitis from ultraviolet cured inks. J. Occup. Med. 19, 113–115. [PubMed: 138725]
  45. Enzmann, H., Bomhard, E., Iatropoulos, M., Ahr, H.J., Schlueter, G., and Williams, G.M. (1998). Short- and intermediate-term carcinogenicity testing – a review. Part 1: The prototypes mouse skin tumour assay and rat liver focus assay. Food Chem. Toxicol. 36, 979–995. [PubMed: 9771562]
  46. Harvey, S.C. (1980). Antimicrobial drugs. In Remington’s Pharmaceutical Sciences (A. Osol, Ed.), p. 1107. Mack Publishing Company, Easton, PA.
  47. Hennings, H., Glick, A.B., Greenhalgh, D.A., Morgan, D.L., Strickland, J.E., Tennenbaum, T., and Yuspa, S.H. (1993). Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc. Soc. Exp. Biol. Med. 202, 1–18. [PubMed: 8424089]
  48. Hollander, M., and Wolfe, D.A. (1973). Nonparametric Statistical Methods, pp. 120–123. John Wiley and Sons, New York.
  49. Honchel, R., Rosenzweig, B.A., Thompson, K.L., Blanchard, K.T., Furst, S.M., Stoll, R.E., and Sistare, F.D. (2001). Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype. Mol. Carcinog. 30, 99–100. [PubMed: 11241757]
  50. Integrated Laboratory Systems (ILS) (1990). Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, P.O. Box 13501, Research Triangle Park, NC 27707.
  51. Jonckheere, A.R. (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41, 133–145.
  52. Kalensky, J. (1987). Allergic contact eczema caused by PVC gloves, induced by pentaerythritol triacrylate (PETA). Cesk. Dermatol. 62, 305–312 (Abstr.).
  53. Kaplan, E.L., and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457–481.
  54. Kirk-Othmer Encyclopedia of Chemical Technology (1978). 3rd ed. (M. Grayson and D. Eckroth, Eds.), Vol. 1, pp. 778–789. John Wiley and Sons, New York.
  55. Leder, A., Kuo, A., Cardiff, R.D., Sinn, E., and Leder, P. (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 87, 9178–9182. [PMC free article: PMC55127] [PubMed: 2251261]
  56. Lenga, R.E., Ed. (1988). The Sigma-Aldrich Library of Chemical Safety Data, ed. 2, Vol. II, p. 2700. Sigma-Aldrich Corporation, Milwaukee.
  57. Liu, E.T. (1990). The role of ras gene mutations in myeloproliferative disorders. Clin. Lab. Med. 10, 797–807. [PubMed: 2272174]
  58. Long, R.E., Knutsen, G., and Robinson, M. (1986). Myeloid hyperplasia in the SENCAR mouse: Differentiation from granulocytic leukemia. Environ. Health Perspect. 68, 117–123. [PMC free article: PMC1474249] [PubMed: 3465532]
  59. McConnell, E.E., Solleveld, H.A., Swenberg, J.A., and Boorman, G.A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI 76, 283–289. [PubMed: 3456066]
  60. MacGregor, J.T., Wehr, C.M., Henika, P.R., and Shelby, M.D. (1990). The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fundam. Appl. Toxicol. 14, 513–522. [PubMed: 2111256]
  61. Mahler, J.F., Flagler, N.D., Malarkey, D.E., Mann, P.C., Haseman, J.K., and Eastin, W. (1998). Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice. Toxicol. Pathol. 26, 501–511. [PubMed: 9715509]
  62. Maronpot, R.R., and Boorman, G.A. (1982). Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol. 10, 71–80. [PubMed: 28094716]
  63. Miller, J.A., and Miller, E.C. (1977). Ultimate chemical carcinogens as reactive mutagenic electrophiles. In Origins of Human Cancer (H.H. Hiatt, J.D. Watson, and J.A. Winsten, Eds.), pp. 605–627. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
  64. Morrison, D.F. (1976). Multivariate Statistical Methods, 2nd ed., pp. 170–179. McGraw-Hill Book Company, New York.
  65. Nagase, H., Bryson, S., Fee, F., and Balmain, A. (1996). Multigenic control of skin tumour development in mice. In 1996 Variation in the Human Genome (Ciba Foundation Symposium 197), pp. 156–180. Wiley, Chichester, England.
  66. National Cancer Institute (NCI) (1987). Summary of data for chemical selection, pentaerythritol triacrylate. Prepared for NCI by Tracor Jitco/Technical Resources, Inc., under contract no. N01-CP-41003.
  67. National Institute for Occupational Safety and Health (NIOSH) (1990). National Occupational Exposure Survey (1981-1983), unpublished provisional data as of July 1, 1990. NIOSH, Cincinnati, OH.
  68. National Toxicology Program (NTP) (1986a). Carcinogenesis Studies of Ethyl Acrylate (CAS No. 140-88-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 259. NIH Publication No. 87-2515. [PubMed: 12748689]
  69. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
  70. National Toxicology Program (NTP) (1986b). Toxicology and Carcinogenesis Studies of Methyl Methacrylate (CAS No. 80-62-6) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Technical Report Series No. 314. NIH Publication No. 87-2570. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC. [PubMed: 12748739]
  71. National Toxicology Program (NTP) (1992). Toxicology and Carcinogenesis Studies of Resorcinol (CAS No. 108-46-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 403. NIH Publication No. 92-2858. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
  72. National Toxicology Program (NTP) (1999). The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. The Results of an Independent Peer Review Evaluation Coordinated by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program Center for the Evaluation of Alternative Toxicological Methods (NICEATM). NIH Publication No. 99-4494. National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Public Health Service, Department of Health and Human Services, Research Triangle Park, NC.
  73. National Toxicology Program (NTP) (2005). Toxicology Studies of Trimethylolpropane Triacrylate (Technical Grade) (CAS No. 15625-89-5) in F344/N Rats, B6C3F1 Mice, and Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal Studies). GMM Report Series No. 3. NIH Publication No. 06-4450. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC. [PMC free article: PMC8935285] [PubMed: 18784763]
  74. Nessel, C.S., Freeman, J.J., Forgash, R.C., and McKee, R.H. (1999). The role of dermal irritation in the skin tumor promoting activity of petroleum middle distillates. Toxicol. Sci. 49, 48–55. [PubMed: 10367341]
  75. Nethercott, J.R. (1978). Skin problems associated with multifunctional acrylic monomers in ultraviolet curing inks. Br. J. Dermatol. 98, 541–552. [PubMed: 148898]
  76. Nethercott, J.R., Jakubovic, H.R., Pilger, C., and Smith, J.W. (1983). Allergic contact dermatitis due to urethane acrylate in ultraviolet cured inks. Br. J. Ind. Med. 40, 241–250. [PMC free article: PMC1069318] [PubMed: 6223656]
  77. Newmark, R.A., and Palazzotto, J. (1990). Carbon-13 NMR analysis of pentaerythritol triacrylate. Appl. Spectroscopy 44, 804–807.
  78. Nylander-French, L.A., and French, J.E. (1998). Tripropylene glycol diacrylate but not ethyl acrylate induces skin tumors in a twenty-week short-term tumorigenesis study in Tg.AC (v-Ha-ras) mice. Toxicol. Pathol. 26, 476–483. [PubMed: 9715506]
  79. Parker, D., and Turk, J.L. (1983). Contact sensitivity to acrylate compounds in guinea pigs. Contact Dermatitis 9, 55–60. [PubMed: 6839739]
  80. Parker, D., Long, P.V., Bull, J.E., and Turk, J.L. (1985). Epicutaneous induction of tolerance with acrylates and related compounds. Contact Dermatitis 12, 146–154. [PubMed: 3995943]
  81. Piegorsch, W.W., and Bailer, A.J. (1997). Statistics for Environmental Biology and Toxicology, Section 6.3.2. Chapman and Hall, London.
  82. Portier, C.J., and Bailer, A.J. (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol. 12, 731–737. [PubMed: 2744275]
  83. Portier, C.J., Hedges, J.C., and Hoel, D.G. (1986). Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program’s carcinogenicity experiments. Cancer Res. 46, 4372–4378. [PubMed: 3731095]
  84. Pritchard, J.B., French, J.E., Davis, B.J., and Haseman, J.K. (2003). The role of transgenic mouse models in carcinogen identification. Environ. Health Perspect. 111, 444–454. [PMC free article: PMC1241426] [PubMed: 12676597]
  85. Radcure Specialties, Inc. (1990a). PETA monomer. Pentaerythritol triacrylate. Radcure Specialties, Inc., Louisville, KY.
  86. Radcure Specialties, Inc. (1990b). Material safety data sheet for pentaerythritol triacrylate. Radcure Specialties, Inc., Louisville, KY.
  87. Sax, N.I., and Lewis, R.J., Sr. (1989). Dangerous Properties of Industrial Materials, 7th ed., pp. 2668–2669. Van Nostrand Reinhold, New York.
  88. Shelby, M.D. (1988). The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204, 3–15. [PubMed: 3277048]
  89. Shelby, M.D., and Witt, K.L. (1995). Comparison of results from mouse bone marrow chromosome aberration and micronucleus tests. Environ. Mol. Mutagen. 25, 302–313. [PubMed: 7607185]
  90. Shelby, M.D., and Zeiger, E. (1990). Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat. Res. 234, 257–261. [PubMed: 2366790]
  91. Shelby, M.D., Erexson, G.L., Hook, G.J., and Tice, R.R. (1993). Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ. Mol. Mutagen. 21, 160–179. [PubMed: 8444144]
  92. Shirley, E. (1977). A non-parametric equivalent of Williams’ test for contrasting increasing dose levels of a treatment. Biometrics 33, 386–389. [PubMed: 884197]
  93. Sistare, F.D., Thompson, K.L., Honchel, R., and DeGeorge, J. (2002). Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals — practical pointers, mechanistic clues, and new questions. Int. J. Toxicol. 21, 65–79. [PubMed: 11936901]
  94. Slaga, T.J., DiGiovanni, J., Winberg, L.D., and Budunova, I.V. (1995). Skin carcinogenesis: Characteristics, mechanisms, and prevention. Prog. Clin. Biol. Res. 391, 1–20. [PubMed: 8532708]
  95. Smith, W.D.L. (1977). Allergic dermatitis due to a triacrylate in ultraviolet cured inks. Contact Dermatitis 3, 312–314. [PubMed: 146587]
  96. Spalding, J.W., French, J.E., Tice, R.R., Furedi-Machacek, M., Haseman, J.K., and Tennant, R.W. (1999). Development of a transgenic mouse model for carcinogenesis bioassays: Evaluation of chemically induced skin tumors in Tg.AC mice. Toxicol. Sci. 49, 241–254. [PubMed: 10416269]
  97. Spalding, J.W., French, J.E., Stasiewicz, S., Furedi-Machacek, M., Conner, F., Tice, R.R., and Tennant, R.W. (2000). Responses of transgenic mouse lines p53(+/–) and Tg.AC to agents tested in conventional carcinogenicity bioassays. Toxicol. Sci. 53, 213–223. [PubMed: 10696769]
  98. Straus, D.S. (1981). Somatic mutation, cellular differentiation, and cancer causation. JNCI 67, 233–241. [PubMed: 7021938]
  99. Tarone, R.E. (1975). Tests for trend in life table analysis. Biometrika 62, 679–682.
  100. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236, 933–941. [PubMed: 3554512]
  101. Tennant, R.W., Stasiewicz, S., Eastin, W.C., Mennear, J.H., and Spalding, J.W. (2001). The Tg.AC (v-Ha-ras) transgenic mouse: Nature of the model. Toxicol. Pathol. 29, 51–59. [PubMed: 11695562]
  102. Thompson, K.L, Rosenzweig, B.A., and Sistare, F.D. (1998). An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness. Toxicol. Pathol. 26, 548–555. [PubMed: 9715514]
  103. Thompson, K.L., Rosenzweig, B.A., Honchel, R., Cannon, R.E., Blanchard, K.T., Stoll, R.E, and Sistare, F.D. (2001). Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA. Mol. Carcinog. 32, 176–186. [PubMed: 11746829]
  104. Trempus, C.S., Mahler, J.F., Ananthaswamy, H.N., Loughlin, S.M., French, J.E., and Tennant, R.W. (1998). Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse. J. Invest. Dermatol. 111, 445–451. [PubMed: 9740239]
  105. Union Carbide Corporation (1979). Evaluation of the Dermal Carcinogenic Potential of Pentaerythritol Acrylate-HF (Project Report No. 42-105). Conducted by The Chemical Hygiene Fellowship of Carnegie Mellon Institute of Research, Pittsburgh, PA, for Union Carbide Corporation, Danbury, CT.
  106. Union Carbide Corporation (1988). Evaluation of the Dermal Carcinogenic Potential of Pentaerythritol Acrylate-HF: Cover letter dated 072888. Conducted by The Chemical Hygiene Fellowship of Carnegie Mellon Institute of Research, Pittsburgh, PA, for Union Carbide Corporation, Danbury, CT.
  107. U.S. Environmental Protection Agency (USEPA) (1991). TSCAPP: 1983 Production Statistics for Chemicals in the Nonconfidential Initial TSCA Chemical Substances Inventory. Office of Pesticides and Toxic Substances, Washington, D.C.
  108. Van Miller, J.P., Garman, R.H., Hermansky, S.J., Mirsalis, J.C., and Frederick, C.B. (2003). Skin irritation, basal epithelial cell proliferation, and carcinogenicity evaluations of a representative specialty acrylate and methacrylate. Regul. Toxicol. Pharmacol. 37, 54–65. [PubMed: 12662909]
  109. Williams, D.A. (1971). A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27, 103–117. [PubMed: 5547548]
  110. Williams, D.A. (1972). The comparison of several dose levels with a zero dose control. Biometrics 28, 519–531. [PubMed: 5037867]
  111. Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. (2000). Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, prechronic, and chronic studies of the NTP Carcinogenesis Bioassay Program. Environ. Mol. Mutagen. 36, 163–194. [PubMed: 11044899]
  112. Yamamoto, S., Urano, K., and Nomura, T. (1998). Validation of transgenic mice harboring the human prototype C-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Toxicol. Lett. 102-103, 473–478. [PubMed: 10022298]
  113. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., Mortelmans, K., and Speck, W. (1987). Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mutagen. 9 (Suppl. 9), 1–110. [PubMed: 3552650]
  114. Zeiger, E., Haseman, J.K., Shelby, M.D., Margolin, B.H., and Tennant, R.W. (1990). Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen. 16 (Suppl. 18), 1–14. [PubMed: 2091921]
Copyright Notice

This is a work of the US government and distributed under the terms of the Public Domain

Bookshelf ID: NBK576065
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.3M)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...